Pharmocann Global (XTAE:PMCN-M) ROCE % : 0.00% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Pharmocann Global ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pharmocann Global's annualized ROCE % for the quarter that ended in Dec. 2023 was 0.00%.

Pharmocann Global ROCE % Historical Data

The historical data trend for Pharmocann Global's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmocann Global ROCE % Chart

Pharmocann Global Annual Data

Trend

Dec09

Dec10

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-177.50

14.85

-57.29

-121.89

-167.88

Pharmocann Global Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															-76.56	-130.07	-264.20	-	-

Pharmocann Global ROCE % Calculation

Pharmocann Global's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-9.602	/	( ( (18.075 - 7.782)	+	(7.102 - 5.956) )	/ 2 )
	=	-9.602	/	( (10.293	+	1.146)	/ 2 )
	=	-9.602	/	5.7195
	=	-167.88 %

Pharmocann Global's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	0	/	( ( (10.75 - 6.344)	+	(7.102 - 5.956) )	/ 2 )
	=	0	/	( ( 4.406	+	1.146 )	/ 2 )
	=	0	/	2.776
	=	0.00 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Pharmocann Global (XTAE:PMCN-M) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Pharmocann Global ROCE % Related Terms

Thank you for viewing the detailed overview of Pharmocann Global's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmocann Global (XTAE:PMCN-M) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmocann Global Ltd (XTAE:PMCN-M) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ramat Yishai, PO Box 305, Kiryat Tivon, ISR, 3601201

Website

https://www.pharmocann.co.il

Pharmocann Global Ltd is an Israel-based company engaged in producing medical-related cannabis products which include oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.

Pharmocann Global (XTAE:PMCN-M) Headlines

No Headlines